Kymera Therapeutics, Inc. (KYMR) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kymera Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.584 Good day everyone. My name is Sophie and I will be your conference operator today. 00:00:05.584 -- 00:00:11.457 At this time, I would like to welcome you to the Chimera Therapeutics third quarter 2025 00:00:11.457 -- 00:00:17.480 results call. All lines have been placed on mute to prevent any background noise. 00:00:17.480 -- 00:00:21.565 After the speaker's remarks, there will be a question and answer session. 00:00:21.565 -- 00:00:25.931 If you would like to ask a question during this time and you have joined via the webinar, 00:00:25.931 -- 00:00:31.278 please use the raise hand icon, which can be found at the bottom of your webinar application. 00:00:31.278 -- 00:00:37.366 If you have joined by phone, please dial star nine on your keypad to raise your hand. 00:00:37.366 -- 00:00:42.532 At this time, I would like to turn the call over to Justine Konigsberg, Vice President 00:00:42.532 -- 00:00:44.834 of Investor Relations. 00:00:44.834 -- 00:00:47.717 Good morning and welcome to Chimera's quarterly update. 00:00:47.717 -- 00:00:52.462 Joining me this morning are Nello Manolfi, founder, president, and CEO, Jared Golub, 00:00:52.462 -- 00:00:56.786 our chief medical officer, and Bruce Jacobs, our chief financial officer. 00:00:56.786 -- 00:01:00.550 Following our prepared remarks, we will open the call to questions from our publishing 00:01:00.550 -- 00:01:05.455 analysts. If you would like to ask a question, please use the raise hand icon, which 00:01:05.455 -- 00:01:08.198 can be found at the bottom of your meeting window. 00:01:08.198 -- 00:01:12.142 And to help us move efficiently through the Q&A session, we ask that you are ready to 00:01:12.142 -- 00:01:16.492 unmute your line when called on. In addition, we ask that you ple...